Innovations for Heart and Vessels has been steadily growing and expanding its operations over the past several years. We have been focused on securing capital necessary for the development of our InFlow valve technology. In this process we have been supported by our valued Partners and Investors, which has led to a huge success in obtaining over 43 million PLN (almost 10 million EUR) in public funding, allowing us to launch the next phase of the InFlow project in May 2024. We remain open for investment opportunities.
Our Investors
-
prof. Paweł Buszman
MD, PhD, EMBA -
Pro Benefis
Familiae Foundation -
prof. Piotr Buszman
MD, PhD -
Piotr Hirnle
MSc, PhD -
1072667
Ontario Ltd. -
Life Sciences
Advisory Sp. z o.o.
-
Marcin Szuba
MD, PhD -
ASI Scanderia
Venture -
Grzegorz Hirnle
MD, PhD
TRIGON Investment Bank
Our efforts in securing private funding are supported and coordinated by TRIGON Investment Bank – one of the oldest investment banking firms in Poland and a leader in the CEE region in terms of the number of IPOs executed on the Warsaw Stock Exchange.
We encourage potential investors to reach out to TRIGON Investment Bank and learn about the opportunity to join Innovations for Heart and Vessels on our journey to transforming the global heart valve replacement market.
https://trigon.pl/en/